RT Journal Article
SR Electronic
T1 Outbreak of P.3 (Theta) SARS-CoV-2 emerging variant of concern among service workers in Louisiana
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.28.21259040
DO 10.1101/2021.07.28.21259040
A1 Rose, Rebecca
A1 Nolan, David J.
A1 LaFleur, Tessa M.
A1 Lamers, Susanna L.
YR 2021
UL http://medrxiv.org/content/early/2021/07/30/2021.07.28.21259040.abstract
AB In May, 2021, during routine oil and gas industrial quarantine/premobilization procedures, four individuals who recently arrived to Louisiana from the Philippines tested positive for SARS-CoV-2. Subsequent genomic analysis showed that all were infected with a Variant of Interest (P.3-Theta). This increases the number of known P.3 infections in the United States to eleven and highlights the importance of genomic surveillance within industries that are prone to rapidly spread the infection.Competing Interest StatementAll authors are employees by BioInfoExperts LLCClinical TrialNot a clinical trialFunding StatementThe project was supported in part by National Science Foundation Small Business Innovation grants # 1830867 and # 2027424Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:A third party review from the WIRB-Copernicus Group (WCG IRB) concluded that this research was exempt from IRB review because it does not meet the definition of human subjects as defined in 45 CFR 46.102All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSequence data is available in GenBank, Accession #'s MZ368550 to MZ368553